摘要
刺山柑Capparis Spinosa L.为白花菜科山柑属植物,源于亚洲中西部干旱地区。我国新疆、西藏境内广有分布,在当地是一种常用的民族传统药物,用于治疗痛风,类风湿性关节炎(rheumatoid arthritis,RA)等。本文研究了刺山柑对多种非特异性炎症模型、疼痛动物模型以及小鼠免疫功能的影响;并进一步建立特异性佐剂关节炎大鼠模型,采用放射免疫、荧光分光等技术对刺山柑抗类风湿性关节炎作用及机理进行了研究,为以后开发刺山柑研制抗类风湿新药提供实验依据。
(1)采用炎症药物筛选常用动物模型对刺山柑进行系统筛选,初步证实刺山柑抗炎有效成分可能集中于醚提部位和醇提部位。
(2)采用二甲苯致小鼠耳廓肿胀及皮肤毛细血管通透性增高、角叉菜胶致小鼠足跖肿胀、醋酸致小鼠扭体反应以及小鼠热板致痛多种动物模型进行整体药效实验。结果证实,刺山柑具有较好的抗炎镇痛作用,降低局部炎症组织前列腺素E2(PGE2)含量可能是其重要作用机制。
(3)采用小鼠碳粒廓清实验和二硝基氟苯(dinitrofluorobenzene,DNFB)致小鼠迟发型过敏反应(delayed type hypersensitivity,DTH)反应实验从免疫功能调节角度研究刺山柑提取物对小鼠免疫功能的影响,结果证实刺山柑提取物具有一定的抑制免疫系统功能的作用,对小鼠血管网状内皮系统的吞噬功能抑制作用较强。
(4)采用大鼠佐剂关节炎模型研究刺山柑抗RA作用与机理。结果证实刺山柑对实验性动物关节炎模型(大鼠佐剂性关节炎adjuvant arthritis,AA)动物病理改变有明显改善作用,能够抑制弗氏完全佐剂引起的大鼠原发性足跖肿胀和继发性足跖肿胀;降低局部炎症组织炎症介质组胺(histamine,HA)、5-羟色胺(5-hydroxytryptamine ,5-HT )含量以及下调血清炎性细胞因子白细胞介素-1β(interleukin-1β,IL-1β)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)可能是其抗RA的主要机制。
Capparis Spinosa L. belongs to the plant family of Capparidaceae and Genus is Capparis. It probably originated from dry regions in west or central Asia. In our country, it is mainly distributed throughout Xinjiang and Tibet, and is used as a folk medicine in the districts. The herbal is widely used in the treatment of rheumatoid arthritis and gout in Xinjiang and Tibet. This paper was conducted to investigate the effect of Capparis Spinosa extract on non-specific inflammation models, pain models and immune function in mice. Moreover, the adjuvant arthritis model was adopted to investigate the pharmacological effects and mechanism of Capparis Spinosa extract on rheumatoid arthritis by means of advanced modern scientific research methods such as radioimmunoassay, ultraviolet spectrophotometry and fluorescence spectrophotometry. The results will provide experimental evidences for Capparis Spinosa’s development in the future.
(1) The herbal was screened systematically by using the classical inflammation and painmodels for effective sites. The results showed the effective components may be contained in the aether extracts and ethanol extracts.
(2) The activities of Capparis Spinosa extracts were tested by several types of models, including auris edema and increased vascular permeability induced by dimethylbenzene in mice, paw edema caused by carrageenin in mice, writhing reaction induced by acetic acid in mice and pain threshold induce by hot plate method in mice. The results showed the extracts of Capparis Spinosa L fruits has great ant-inflammatory and analgestic action, and inhibiting the synthesize or release of PGE2 in inflammatory tissue might be the major mechanism
(3) Carbon clearance test and dinitrofluorobenzene-induced delayed type hypersensitivity test(DTH)were used to evaluate the immunomodulating effects of Capparis spinosa extract on non-specific and specific immunologic function in mice. The results showed Capparis Spinosa extracts could inhibited phagocytosis of Mononuclear macrophage in mice.
(4) The pharmacological effects and mechanism of Capparis Spinosa extract on rheumatoid arthritis was investigated by using the adjuvant arthritis model. The results showed Capparis Spinosa extracts could improved the pathological changes in AA rats .It could the primary paw swelling and the secondary hind paw swelling in AA rats . Reducing the content of HA and 5-HT in inflammatory tissue as well as serum level of IL-1βand TNF-αmight be the major mechanism.
引文
[1] A1tschuler EL. Parvovirus t119 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning. Lancet, 1999: 18: 1026
[2]叶任高.内科学,人民卫生出版社, 2001, 897-904
[3] PileK, Camineri J, Jessop J, et a1. HLA-DR4 association with rheumatoid arthritis: comment on the article by Nelson et a1. Arthritis Rheum, 1995, 38: 298-300
[4]费克香,雷元卫.类风湿性关节炎免疫功能异常的研究进展.国外医学免疫学分册, 1999, 22(6): 323-326
[5] Straub RH, Paimela L, Peltomaa R, et a1. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum, 2002, 46(3): 654-662
[6]蒋明,朱立平,林孝义.风湿病学,上册.北京:科学出版社, 1995: 815-844
[7]张进玉.类风湿性关节炎(第二版),人民卫生出版社. 1998: 178-180
[8] Simon AK, Seipelt E, Siepe J. Dibergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA, 1994; 91: 8562-6
[9] Wernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membranc cell cultures. Athritis Rheum, 1985;28: 764-52
[10] Breedveld FC. New insights in the pathogenesis of rheumatoid arthritis. J Rheumatol, 1998;25(Suppl53): 3-7
[11]戴生明,韩星海.类风湿关节炎骨侵蚀的发生机制.中华风湿病学杂志, 2002;6(3): 201-203
[12] Firestein GS, Zvaifer NJ. How important are T cell in chronic rheumatoid synovitis. Athritis Rheum,1990;33: 768-73
[13]黄启阳,于孟学.应用细胞因子及其拮抗剂治疗类风湿性关节炎的进展.北京医学, 1996;18(2): 102
[14] FionulaM, Bremman, Ravinder N, Maini, Mare Feldmann. Role ofpro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol, 1998;20: 133-147
[15]余宜龙,聂宇,细胞因子与类风湿性关节炎, J Huai hai Med, Dec, 2004, 22(6): 532-534
[16] M. Feldmann, F.M. Brennan, R.N. Maini, Role of cytokines in rheumatoid arthritis, Annu. Rev. Immunol, 1996, 14: 397-440
[17] Jae-Gyun Jeonga, Jong-Mook Kimb, Hongchan Chob, Woong Hahnb, Seung Shin Yub, Sunyong Kima, Effects of IL-1βon gene expression in human rheumatoid synovial fibroblasts, Biochemical and Biophysical Research Communications, 2004, 234: 3-7
[18]乌兰,梁文波,柳晓光等,大鼠佐剂性关节炎血清细胞因子水平与炎症及病理变化的相关性研究,大连大学学报, 2001, 22(2): 70-76
[19]徐卫东,张春才,孟济明.细胞因子与软骨损伤修复.中华风湿病学杂志, 1999, 3(1): 57-59
[20] Dinarello CA. Inteleukin-1 and tumour necrosis factor: effector cytokines in autoimmune diseases. Semi Immunol, 1992, 4: 133-145
[21]李桂兰,饶光立,邱继中.类风湿性关节炎的药物治疗近况.中华医学杂志, 2003, 11(2): 27-28
[22] Nell VP, Machold KP, Eberl G, et a1. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis Rheumatology(Oxford), 2004, 43(7): 906-914
[23] Weaver AL. The impact of new bilogicals in the treatment of rheumatoid arthritis. Rheumatology (Oxford), 2004, 43(Suppl～3): 7-23
[24]施桂英.非甾体类抗炎药物治疗风显病的新进展.新医学. 1998, 29(1): 13
[25]张秀英,董砚奉.类风湿性关节炎的治疗进展.中华实用医学. 2004, 6(16): 36-38
[26]杨云柯.中医药治疗类风湿性关节炎现状.中国临床医学. 2005, 12(6): 1175-6
[27]李斌,罗永明.中药活性成分治疗类风湿性关节炎的研究.中药材. 2003, 26(4): 298-299
[28]王希海,卢英民,马轶涛.雷公藤多甙对胸腺T细胞免疫功能的动态研究.中药药理与临床, 1999, 15(5): 26
[29]毕晓扬,白人骁.正清风痛宁治疗类风湿性关节炎和强直性脊柱炎50例临床观察.中草药, 2000, 31(4): 286
[30]陈立仁.昆明山海棠治疗类风湿性关节炎120例疗效观察.中国民族民间医药杂志, 1996, 22: 9
[31]张革.独活胶囊风寒湿、腰膝痛的药效学研究.现代康复, 2001, 5(3): 126
[32]杨俊贤.吡啶-2, 6(1H, 3H)二酮生物碱对ADP、AA、Collagen诱导的兔血小板聚集的影响.中国药理学通报, 1998, 14(1): 24
[33]中国科学院中国植物志编辑委员会.中国植物志.32卷.第2分册.北京:科学出版社,1983.495-497
[34]刘媖心.中国沙漠植物志.第二卷.北京:科学出版社,1987. 10
[35] Levizou. E, Drillas.P, Kyparissis A. Exceptional photosynthetic performance of Capparis spinosa L.under adverse conditions of Mediterranean summer. Photosynthetica. 2004, 42 (2): 229-235
[36] ? zcan, M., Akgül, A. Influence of species, harvest date and size on composition of capers (Capparis spp.) flower buds. Nahrung 1998, 42: 102-105
[37] Rodrigo M., Lazaro M.J, Alvarruiz A., et aL. Composition of capers (Capparis spinosa): influence of cultivar, size and harvest date. JournaL of Food Science. 1992, 57: 1152–1154
[38] ?ali? ?, Kuruüzüm,A, Rüedi,P. 1H-Indole-3-acetonitrile glycosides from Capparis spinosa fruits. Phytochemistry 1999,50: 1205–1208
[39] ?ali? ?, Kuruüzüm,A, Piergiorgio A . (6S)-Hydroxy-3-oxo-a-ionol glucosides from Capparis spinosa fruits. Phytochemistry. 2002, 59 :451–457
[40] Bertrand Matth?us, Musa ?zcan. Glucosinolate Composition of Young Shoots and Flower Buds of Capers (Capparis Species) Growing Wild in Turkey. J. Agric. Food Chem. 2002, 50: 7323-7325
[41] Suleiman Afsharypuor, Koorosh Jeiran, Amir Arefian Jazy. First investigation of the flavour profiles of the leaf,ripe fruit and root of Capparis spionsa var.mucronifolia from Iran. Pharmaceutica Acta HeLvetiae 1998, 72:307-309
[42] Khanafar MA, Sabri SS, Zarga MH. The chemical constituents of Capparis spinosa ofJordanian origin. Nat Prod Res. 2003, 17(1):9-14
[43] Al-Said M.S, Abdelsattar E.A., Khalifa S.I., et aL. Isolation and identification of an anti-inflammatory principle from Capparis spinosa. Pharmazie 1988, 43: 640–641.
[44] Vincenza Romeo, Marisa Ziino , Daniele Giuffrida, et aL. Flavour profile of capers (Capparis spinosa L.) from the Eolian Archipelago by HS-SPME/GC–MS. Food Chemistry. 2007, 101(3): 1272-1278
[45] Sharaf M, El-Ansari MA, Saleh NAM. Flavonoids of Four CLeome and Three Capparis Species. Biochem Syst EcoL 1997, 25:161
[46] Sharaf M, El-Ansari MA, Saleh NAM. Quercetin triglycoside from Capparis spinosa. Fitoterapia. 2000, 71: 46-49
[47] Gadgoli C, Mishra S.H. Antihepatotoxic activity of p-methoxy benzoic acid from Capparis spinosa. JournaL of EthnopharmacoLogy. 1999, 66: 187–192
[48] Ziyyat A., Legssyer A., Mekhfi H., et aL. Phytotherapy of hypertension and diabetes in oriental Morocco. JournaL of EthnopharmacoLogy. 1997, 58: 45–54
[49] Jouad H., Haloui M., Rhiouani H., et aL. Ethnopharmacological survey of medicinal plants used or the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco (Fez-Boulemane). JournaL of EthnopharmacoLogy 2001, 77: 175–182
[50] Eddouks M., Lemhadri A., Michel J.-B. Caraway and caper: a potential anti-hyperglycaemic plants in diabetic rats. JournaL of EthnopharmacoLogy 2004, 94: 143–148
[51] M. Eddouks, A. Lemhadri , J.-B. Michel. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. JournaL of EthnopharmacoLogy. 2005, 98: 345–350
[52] Kritchevsky D. Fiber, lipids and atherosclerosis. American JournaL of CLinicaL Nutrition. 1978, 31: 65–74
[53]Sharma S.B, Nasir A., Prabhu K.M., et aL. Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jamboLana in alloxan-induced diabetic rabbits. JournaL of EthnopharmacoLogy 2003, 85: 201–206
[54] Germano MP, De Pasquale R, D'Angelo V. Evaluation of extracts and isolatedfraction from Capparis spinosa L. buds as an antioxidant source. J Agric Food Chem. 2002, 50(5):1168
[55] Bonina F, Puglia C, Ventura D. In vitro antioxidant and in vivo photoprotective effects of a lyophilized extract of Capparis spinosa L buds. J Cosmet Sci. 2002, 53(6):321-35
[56] Mahasneh AM. Screening of some indigenous Qatari medicinal plants for antimicrobial activity. Phytother Res. 2002, 16(8):751-3
[57] Ali-Shtayeh MS, Abu Ghdeib SI. Antifungal activity of plant extracts against dermatophytes. Mycoses. 1999, 42(11-12):665-72
[58] Adel M. Mahasneh , Jameel A. Abbas , Ahmad A. El-Oqlah. Antimicrobial Activity of Extracts of Herbal Plants used in the Traditional Medicine of Bahrain. Phytotherapy Research 1998, 10(3): 251-253
[59] Ageel AM, Parmar NS, Mossa JS. Anti-inflammatory activity of some Saudi Arabian medicinal plants. Agents Actions. 1986, 17(3-4):383-4
[60] Victor Rimbau , Esther Risco, Salvador Canigueral. Antiinflammatory Activity of Some Extracts from Plants used in the Traditional Medicine of North-African Countries. Phytotherapy Research. 1996,10(5):421-423
[61] Trombetta D, Occhiuto F, Perri D. Antiallergic and antihistaminic effect of two extracts of Capparis spinosa L. flowering buds. Phytother Res. 2005, 19(1):29-33
[62] Panico A, Cardile V, Garufi F. Protective effect of Capparis spinosa on chondrocytes. Life Sci. 2005, 77: 2479-2488
[63]李仪奎.中药药理实验方法学.上海:科学技术出版社, 1991. 350-3
[64]徐叔云等主编.药理实验方法学.第三版.北京:人民卫生出版社, 2001. 911-3
[65]陈奇主编.中药药理研究方法学.北京:人民卫生出版社, 1993. 370-1
[66]张立运,杨春.保护风蚀地的刺山柑.植物杂志, 2004,(1): 4
[67]毕涉等主编.炎症和抗炎药物.北京:人民卫生出版社, 1993.1-2
[68]吾斯曼·吐尔逊.刺山柑(老鼠瓜)的药用探索.中国民族医药杂志, 2006, 4: 33
[69] Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios TK, Kogopoulou O, Moutsopoulos HM, Thyphronitis G. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren’s syndrome. Clin ExpImmunol, 2002;128(3): 562-8
[70]柏干苹,方勇飞.细胞因子与类风湿性关节炎.临床内科杂志. 2001, 4: 257
[71] Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol, 1989, 75(2): 306—310